CurveBeam AI (CRVA.F) Stock Overview

Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. More details

CRVA.F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	5/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 92.9% below our estimate of its fair value

Earnings are forecast to grow 65.4% per year

Risk Analysis

Shares are highly illiquid

Has less than 1 year of cash runway

Does not have a meaningful market cap ($44M)

CRVA.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

CurveBeam AI Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for CurveBeam AI
Historical stock prices
Current Share Price	AU$0.054
52 Week High	AU$0.054
52 Week Low	AU$0.054
Beta	1.74
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	CRVA.F	US Medical Equipment	US Market
7D	0%	1.8%	1.2%
1Y	n/a	0.8%	17.9%

Return vs Industry: Insufficient data to determine how CRVA.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how CRVA.F performed against the US Market.

Price Volatility

Is CRVA.F's price volatile compared to industry and market?
CRVA.F volatility
CRVA.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.3%
Market Average Movement	6.4%
10% most volatile stocks in US Market	17.3%
10% least volatile stocks in US Market	3.0%

Stable Share Price: CRVA.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CRVA.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Greg Brown	curvebeamai.com

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America and internationally. The company provides orthopedic products, such as HiRise for bilateral weight bearing CT imaging; LineUP for bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities; and CubeVue Software visualization tools. It also offers software CurveBeam AI Autometrics for automatically segment foot and ankle datasets, as well as 3D measurement tools, including Axiometrics and TALAS.

CurveBeam AI Limited Fundamentals Summary

How do CurveBeam AI's earnings and revenue compare to its market cap?
CRVA.F fundamental statistics
Market cap	US$28.75m
Earnings (TTM)	-US$11.13m
Revenue (TTM)	US$7.99m

3.6x

P/S Ratio

-2.6x

P/E Ratio

Is CRVA.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRVA.F income statement (TTM)
Revenue	AU$12.10m
Cost of Revenue	AU$6.67m
Gross Profit	AU$5.43m
Other Expenses	AU$22.27m
Earnings	-AU$16.84m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.043
Gross Margin	44.89%
Net Profit Margin	-139.24%
Debt/Equity Ratio	45.5%

How did CRVA.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/09/24 13:14
End of Day Share Price	2025/06/27 00:00
Earnings	2025/06/30
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CurveBeam AI Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Hester	Bell Potter
null null	Lodge Partners Pty Ltd.

CurveBeam AI LimitedOTCPK:CRVA.F Stock Report